Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amylyx Pharmaceuticals (AMLX) Asset Utilization Ratio (2022 - 2025)

Amylyx Pharmaceuticals has reported Asset Utilization Ratio over the past 4 years, most recently at 0.0 for Q3 2025.

  • Quarterly results put Asset Utilization Ratio at 0.0 for Q3 2025, down 100.4% from a year ago — trailing twelve months through Sep 2025 was 0.0 (down 100.4% YoY), and the annual figure for FY2024 was 0.25, down 70.66%.
  • Asset Utilization Ratio for Q3 2025 was 0.0 at Amylyx Pharmaceuticals, down from 0.0 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for AMLX hit a ceiling of 0.78 in Q1 2024 and a floor of 0.0 in Q3 2025.
  • Median Asset Utilization Ratio over the past 4 years was 0.25 (2023), compared with a mean of 0.31.
  • Biggest five-year swings in Asset Utilization Ratio: soared 39938.45% in 2023 and later tumbled 100.4% in 2025.
  • Amylyx Pharmaceuticals' Asset Utilization Ratio stood at 0.09 in 2022, then skyrocketed by 648.14% to 0.71 in 2023, then plummeted by 43.13% to 0.4 in 2024, then plummeted by 100.57% to 0.0 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.0 (Q3 2025), 0.0 (Q2 2025), and 0.0 (Q1 2025) per Business Quant data.